Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 4, 2025 | (Q2)Jun 14, 2025 | (Q1)Mar 22, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Oct 5, 2024 | (Q2)Jun 15, 2024 | (Q1)Mar 23, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.57%1.85B | -0.78%1.4B | -18.97%692M | 3.68%6.06B | 11.71%1.69B | 0.76%2.12B | 6.19%1.41B | -6.56%854M | 19.08%5.85B | 19.35%1.51B |
| Net income from continuing operations | 100.45%882M | -2.85%648M | -28.86%350M | -4.91%2.5B | 263.16%897M | -53.39%440M | -14.71%667M | -24.54%492M | -6.35%2.63B | 82.96%247M |
| Operating gains losses | 161.76%21M | -1,450.00%-27M | -118.75%-3M | 130.77%8M | -44.19%24M | -3,500.00%-34M | 109.52%2M | 132.65%16M | 96.46%-26M | 118.53%43M |
| Depreciation and amortization | -12.07%692M | -13.38%518M | 2.28%627M | 3.16%2.61B | 2.00%612M | 3.15%787M | 2.22%598M | 5.33%613M | 5.11%2.53B | 3.99%600M |
| Asset impairment expenditure | 500.00%6M | --1M | ---- | -8.33%22M | -8.70%21M | 0.00%1M | --0 | ---- | -20.00%24M | 4.55%23M |
| Unrealized gains and losses of investment securities | -95.10%25M | -132.14%-9M | -70.00%9M | 23.35%-128M | -202.25%-363M | 393.10%510M | -9.68%28M | 100.00%30M | -211.33%-167M | -47.95%355M |
| Deferred tax | 11.55%338M | 130.53%302M | 7.20%283M | 6.95%908M | 24.26%210M | 50.00%303M | -46.31%131M | 12.82%264M | 2.17%849M | -20.66%169M |
| Other non cashItems | 100.00%334M | 1,746.15%480M | 108.65%434M | -15.58%1.02B | -14.16%285M | -50.88%167M | -74.76%26M | 447.37%208M | 15.17%1.21B | 38.91%332M |
| Change In working capital | -150.00%-126M | -203.50%-266M | -88.54%-724M | 241.53%334M | 274.17%209M | -11.27%252M | 310.66%257M | -38.13%-384M | 78.49%-236M | 46.90%-120M |
| -Change in receivables | -886.67%-118M | 31.36%-81M | 23.58%456M | 39.90%-238M | -76.22%-504M | 287.50%15M | 45.12%-118M | 226.55%369M | 45.75%-396M | 5.30%-286M |
| -Change in inventory | -1.49%-273M | -200.00%-176M | 123.97%29M | -1,217.78%-503M | -525.00%-289M | 14.87%-269M | 1.73%176M | -200.83%-121M | 106.45%45M | 166.67%68M |
| -Change in prepaid assets | -215.87%-199M | -61.76%13M | 44.53%-71M | -850.00%-45M | -36.72%112M | -16.67%-63M | 165.38%34M | -96.92%-128M | 20.00%6M | 101.14%177M |
| -Change in payables and accrued expense | -20.98%467M | 97.32%-7M | -45.06%-734M | 1,225.00%742M | 1,580.65%918M | -6.19%591M | -667.65%-261M | -5.86%-506M | -86.00%56M | -153.91%-62M |
| -Change in other working capital | 86.36%-3M | -103.52%-15M | -20,300.00%-404M | 613.21%378M | -64.71%-28M | -168.75%-22M | 7,000.00%426M | -93.75%2M | 171.62%53M | 32.00%-17M |
| Interest received (cash flow from operating activities) | -39.13%14M | -56.00%11M | 11.76%19M | 10.96%81M | 0.00%16M | 4.55%23M | 47.06%25M | -5.56%17M | 10.61%73M | 33.33%16M |
| Tax refund paid | -0.90%-336M | 19.82%-263M | 24.63%-303M | -25.00%-1.29B | -46.05%-222M | -17.67%-333M | -11.19%-328M | -34.90%-402M | -73.65%-1.03B | 2.56%-152M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.57%1.85B | -0.78%1.4B | -18.97%692M | 3.66%6.07B | 11.63%1.69B | 0.76%2.12B | 6.19%1.41B | -6.56%854M | 19.12%5.85B | 19.51%1.51B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 15.52%-381M | 6.32%-726M | -92.89%-434M | -38.06%-2.3B | -506.43%-849M | 18.88%-451M | -27.47%-775M | 37.85%-225M | 35.43%-1.67B | 74.68%-140M |
| Net PPE purchase and sale | -1.97%-621M | -19.31%-519M | 40.40%-208M | -4.29%-2.02B | -0.97%-625M | 2.40%-609M | -12.40%-435M | -14.43%-349M | -33.82%-1.94B | 9.10%-619M |
| Net intangibles purchas and sale | 8.06%-114M | 4.88%-78M | 12.50%-70M | 7.37%-377M | 0.00%-91M | 6.06%-124M | 10.87%-82M | 13.04%-80M | 2.86%-407M | 18.02%-91M |
| Net investment purchase and sale | 171.43%75M | 466.67%99M | -314.47%-326M | -225.00%-95M | -164.94%-113M | -50.00%-105M | -196.43%-27M | 371.43%152M | -67.93%76M | 363.64%174M |
| Net other investing changes | -27.91%279M | 1.30%-228M | 226.92%170M | -68.33%190M | -105.05%-20M | 43.33%387M | -47.13%-231M | -42.86%52M | 531.65%600M | 29.84%396M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 15.52%-381M | 6.32%-726M | -92.89%-434M | -38.06%-2.3B | -506.43%-849M | 18.88%-451M | -27.47%-775M | 37.85%-225M | 35.43%-1.67B | 74.68%-140M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 55.21%-1.1B | -418.95%-794M | 12.42%-1B | -3.24%-4.18B | 38.15%-428M | -40.74%-2.46B | 75.36%-153M | -15.34%-1.14B | -34.70%-4.05B | -17.09%-692M |
| Net issuance payments of debt | 101.41%15M | -98.18%16M | 92.42%-30M | -48.54%-407M | 200.00%177M | -140.63%-1.07B | 219.27%878M | -140.00%-396M | -164.93%-274M | -49.57%59M |
| Net common stock issuance | 17.22%-495M | 13.89%-496M | -15.62%-385M | 0.48%-1.89B | 5.26%-378M | 2.76%-598M | -20.50%-576M | 17.16%-333M | -9.99%-1.89B | 0.50%-399M |
| Net preferred stock issuance | --0 | --0 | ---225M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash dividends paid | -5.46%-251M | -9.62%-114M | -20.41%-118M | -4.24%-443M | 72.73%-3M | -10.70%-238M | -0.97%-104M | -2.08%-98M | -3.41%-425M | 0.00%-11M |
| Interest paid (cash flow from financing activities) | -0.80%-379M | -5.45%-271M | -6.73%-317M | -6.31%-1.2B | -1.92%-266M | -12.91%-376M | -4.47%-257M | -4.21%-297M | -12.16%-1.13B | -9.21%-261M |
| Net other financing activities | 105.62%10M | 175.53%71M | 489.47%74M | 24.77%-249M | 152.50%42M | -28.06%-178M | -36.23%-94M | 55.81%-19M | -13.36%-331M | -40.35%-80M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 55.21%-1.1B | -418.95%-794M | 12.42%-1B | -3.24%-4.18B | 38.15%-428M | -40.74%-2.46B | 75.36%-153M | -15.34%-1.14B | -34.70%-4.05B | -17.09%-692M |
| Net cash flow | ||||||||||
| Beginning cash position | -51.49%1.17B | -32.82%1.3B | -16.44%2.05B | 5.97%2.45B | -7.87%1.63B | 22.84%2.42B | 3.58%1.94B | 5.97%2.45B | -22.49%2.31B | -19.24%1.77B |
| Current changes in cash | 146.65%369M | -126.15%-125M | -44.55%-743M | -405.15%-415M | -39.50%412M | -293.53%-791M | 403.16%478M | -17.08%-514M | 120.18%136M | 458.20%681M |
| Effect of exchange rate changes | 300.00%2M | -600.00%-5M | -125.00%-1M | 500.00%12M | 166.67%8M | 50.00%-1M | 0.00%1M | --4M | -33.33%2M | 0.00%3M |
| End cash Position | -5.10%1.55B | -51.49%1.17B | -32.82%1.3B | -16.44%2.05B | -16.44%2.05B | -7.87%1.63B | 22.84%2.42B | 3.58%1.94B | 5.97%2.45B | 5.97%2.45B |
| Free cash from | -19.38%1.12B | -10.24%798M | -2.59%414M | 4.59%3.67B | 21.17%973M | 2.90%1.38B | 5.21%889M | -17.79%425M | 15.16%3.51B | 69.41%803M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.